Navigation Links
ORFLO Launches First Hands-free Mini Automated Cell Counter
Date:4/3/2011

ORLANDO, Fla., April 3, 2011 /PRNewswire/ -- ORFLO Technologies announced the international launch of Moxi™ Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.

(Photo: http://photos.prnewswire.com/prnh/20110403/SF76326 )

"The Moxi Z mini cell counter sets a new bar for the cell counting community," said Manju Sethi, Vice President of Business Development, "The instrument eliminates virtually all of the drawbacks of current cell counting methods."

Today, cell counting is often performed by using hemocytometers that involve laborious manual counting or by using large, imprecise image-based counting systems.  When more accurate data is needed, scientists turn to flow cytometers that can be very costly.

Moxi Z combines two powerful methods, the Coulter Principle which is the gold standard for cell counting and a patented thin-film sensor technology developed by ORFLO.  This unique instrument has the performance of high-end instruments yet is miniaturized, affordable and simple to operate without the need for costly reagents or maintenance contracts.  

In just 8 seconds per measurement, the instrument provides accurate cell size and count determinations and an indicator of dead versus live cells with its Moxi Viability Index - an important criterion for scientists who are analyzing cell cultures.  The Moxi Z is the first portable instrument to provide cell viability without the use of reagents or dyes.  Moxi Z's disposable cassettes offer superior ease of use and cost effectiveness with two tests per cassette.

"Cell science is evolving rapidly today, and Moxi z plays a revolutionary role in optimizing the scientist's toolkit to quickly and affordably answer many of the quantitative and qualitative questions that scientists ask themselves about their cell cultures," summarizes Ted Ayliffe, ORFLO founder and CEO.

Orflo Technologies is a Seattle-based, privately-held leading edge biotechnology company with a strong intellectual property portfolio focused on developing high-precision, inexpensive portable instruments for cell analysis.  Orflo is leveraging its innovative proprietary technology platform to revolutionize cell counting in both the life science and diagnostic industries.  ORFLO and Moxi are trademarks of ORFLO Technologies.For more information, contact Pia Ayliffe at: http://www.orflo.com/Address: 18916 North Creek Parkway, Building 2, Bothell, WA 98011Phone: +1 425 806-0002Email: info@orflo.com
'/>"/>

SOURCE ORFLO Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hospira Launches Enhanced TheraDoc™ Clinical Surveillance System to Support Patient Safety and Help Improve Care
2. Online Forum for Accountable Care Organization Developments Launches Today; Squire Sanders Sponsorship Reflects Commitment to Leadership in Emerging Health Policy Debate
3. Ventana Medical Systems, Inc. Launches Virtuoso Software for Digital Pathology
4. Songbird® Hearing Launches the Worlds First High-Quality, Low-Cost Sound Enhancement Product Available at Retail
5. Nutraceutical International Corporation Launches Product Featuring ChromaDexs pTeroPure™ Pterostilbene
6. Metabolic Solutions Development Company Launches Phase 2a Trial of Its Second Compound to Treat Type 2 Diabetes
7. Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited
8. CareFusion Launches Innovative Vertebral Balloon That Gives Surgeons More Options to Treat Spinal Fractures
9. Havas Drive Launches New Services Aimed at Improving Digital and Web Accessibility
10. WaferGen Launches High-Throughput SmartChip Human MicroRNA Panel V2
11. Telome Health, Inc. Launches With Exclusive IP Portfolio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... , July 26, 2017 E.I. Medical Imaging ... the Bimini SharkLab to custom design the worlds first ultrasound system ... sharks in their native habitat. In preparation for a ... Channel,s Shark Week, Dr. Guttridge approached EIMI with the ... diagnosis directly to hammerhead sharks underwater. ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
(Date:7/25/2017)... CAMBRIDGE, Massachusetts , July 25, 2017 /PRNewswire/ ... drugs to treat rare nervous system diseases, has concluded a ... and market the drug SOM0226 against transthyretin amyloidosis (ATTR). Before ... promising results in a Phase 2 study conducted in ... in the United States ...
Breaking Medicine Technology:
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... ... services business of UnitedHealth Group (NYSE: UNH), has made a multi-million dollar partnership ... affected by post-traumatic stress disorder (PTSD) and traumatic brain injuries (TBI) over the ...
(Date:8/20/2017)... ... ... Are you an adult with gluten intolerance or Celiac disease living with ... participating in a research study that focuses on family interactions when dealing with dietary ... aspects of adults who have gluten sensitivities who cohabitate with other adults who may ...
(Date:8/19/2017)... , ... August 19, 2017 , ... ... that it is the first organization with pending recognition status from the Centers ... Program (“DPP”) via group telehealth classes and live video conferencing. , The ...
(Date:8/19/2017)... ... August 19, 2017 , ... ... joined its Orlando location as an interventional pain management physician. He brings a ... the treatment of migraine headaches, and significant experience in spinal cord stimulation for ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... International, LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport ... a definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner ...
Breaking Medicine News(10 mins):